391 related articles for article (PubMed ID: 26226143)
41. Behavioral neuroscience of autism.
Takumi T; Tamada K; Hatanaka F; Nakai N; Bolton PF
Neurosci Biobehav Rev; 2020 Mar; 110():60-76. PubMed ID: 31059731
[TBL] [Abstract][Full Text] [Related]
42. Altered Microglia in the Amygdala Are Involved in Anxiety-related Behaviors of a Copy Number Variation Mouse Model of Autism.
Shigemori T; Sakai A; Takumi T; Itoh Y; Suzuki H
J Nippon Med Sch; 2015; 82(2):92-9. PubMed ID: 25959200
[TBL] [Abstract][Full Text] [Related]
43. Searching for the gut microbial contributing factors to social behavior in rodent models of autism spectrum disorder.
Needham BD; Tang W; Wu WL
Dev Neurobiol; 2018 May; 78(5):474-499. PubMed ID: 29411548
[TBL] [Abstract][Full Text] [Related]
44. Chronic subconvulsive activity during early postnatal life produces autistic behavior in the absence of neurotoxicity in the juvenile weanling period.
Friedman LK; Kahen BA
Behav Brain Res; 2019 Nov; 374():112046. PubMed ID: 31376443
[TBL] [Abstract][Full Text] [Related]
45. Advances in understanding the pathophysiology of autism spectrum disorders.
Yenkoyan K; Grigoryan A; Fereshetyan K; Yepremyan D
Behav Brain Res; 2017 Jul; 331():92-101. PubMed ID: 28499914
[TBL] [Abstract][Full Text] [Related]
46. Oxytocin in animal models of autism spectrum disorder.
Peñagarikano O
Dev Neurobiol; 2017 Feb; 77(2):202-213. PubMed ID: 27603327
[TBL] [Abstract][Full Text] [Related]
47. The ketogenic diet modifies social and metabolic alterations identified in the prenatal valproic acid model of autism spectrum disorder.
Ahn Y; Narous M; Tobias R; Rho JM; Mychasiuk R
Dev Neurosci; 2014; 36(5):371-80. PubMed ID: 25011527
[TBL] [Abstract][Full Text] [Related]
48. Behavioral variability and autism spectrum disorder.
Rodriguez NM; Thompson RH
J Appl Behav Anal; 2015; 48(1):167-87. PubMed ID: 25293678
[TBL] [Abstract][Full Text] [Related]
49. A neuroligin-3 mutation implicated in autism causes abnormal aggression and increases repetitive behavior in mice.
Burrows EL; Laskaris L; Koyama L; Churilov L; Bornstein JC; Hill-Yardin EL; Hannan AJ
Mol Autism; 2015; 6():62. PubMed ID: 26583067
[TBL] [Abstract][Full Text] [Related]
50. [Diagnosis and Therapeutic Interventions in Autism Spectrum Disorders in Adulthood].
Krämer K; Gawronski A; Vogeley K
Fortschr Neurol Psychiatr; 2016 Sep; 84(9):578-88. PubMed ID: 27607072
[TBL] [Abstract][Full Text] [Related]
51. Behavioural methods used in rodent models of autism spectrum disorders: current standards and new developments.
Wöhr M; Scattoni ML
Behav Brain Res; 2013 Aug; 251():5-17. PubMed ID: 23769995
[TBL] [Abstract][Full Text] [Related]
52. Genetic Animal Models for Autism Spectrum Disorder.
Schroeder JC; Reim D; Boeckers TM; Schmeisser MJ
Curr Top Behav Neurosci; 2017; 30():311-324. PubMed ID: 26602248
[TBL] [Abstract][Full Text] [Related]
53. Functional significance of rare neuroligin 1 variants found in autism.
Nakanishi M; Nomura J; Ji X; Tamada K; Arai T; Takahashi E; Bućan M; Takumi T
PLoS Genet; 2017 Aug; 13(8):e1006940. PubMed ID: 28841651
[TBL] [Abstract][Full Text] [Related]
54. Neuroligin-3-deficient mice: model of a monogenic heritable form of autism with an olfactory deficit.
Radyushkin K; Hammerschmidt K; Boretius S; Varoqueaux F; El-Kordi A; Ronnenberg A; Winter D; Frahm J; Fischer J; Brose N; Ehrenreich H
Genes Brain Behav; 2009 Jun; 8(4):416-25. PubMed ID: 19243448
[TBL] [Abstract][Full Text] [Related]
55. The role of the endocannabinoid system as a therapeutic target for autism spectrum disorder: Lessons from behavioral studies on mouse models.
Pietropaolo S; Marsicano G
Neurosci Biobehav Rev; 2022 Jan; 132():664-678. PubMed ID: 34813825
[TBL] [Abstract][Full Text] [Related]
56. Behavioral profiles of mouse models for autism spectrum disorders.
Ey E; Leblond CS; Bourgeron T
Autism Res; 2011 Feb; 4(1):5-16. PubMed ID: 21328568
[TBL] [Abstract][Full Text] [Related]
57. Behavioral screening tools for identifying autism in macaques: existing and promising tests.
Qin D; Wu S; Chen Y; Hu X
Brain Res Bull; 2019 Mar; 146():87-93. PubMed ID: 30605712
[TBL] [Abstract][Full Text] [Related]
58. Modeling of autism genetic variations in mice: focusing on synaptic and microcircuit dysfunctions.
Qiu S; Aldinger KA; Levitt P
Dev Neurosci; 2012; 34(2-3):88-100. PubMed ID: 22572629
[TBL] [Abstract][Full Text] [Related]
59. Male-specific alteration in excitatory post-synaptic development and social interaction in pre-natal valproic acid exposure model of autism spectrum disorder.
Kim KC; Kim P; Go HS; Choi CS; Park JH; Kim HJ; Jeon SJ; Dela Pena IC; Han SH; Cheong JH; Ryu JH; Shin CY
J Neurochem; 2013 Mar; 124(6):832-43. PubMed ID: 23311691
[TBL] [Abstract][Full Text] [Related]
60. Clinical differences in children with autism spectrum disorder with and without food selectivity.
Postorino V; Sanges V; Giovagnoli G; Fatta LM; De Peppo L; Armando M; Vicari S; Mazzone L
Appetite; 2015 Sep; 92():126-32. PubMed ID: 25998237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
